OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AMENYSE$235.5068

AMETEK INC/

Electrical Components & EquipmentVerified

Capital Structure and Liquidity AMETEK has a market capitalization of $54.13 billion and a price-to-earnings ratio of 135.53, indicating a high valuation relative to earnings. The company's liquidity position is characterized by a current ratio of 1.14, which is close to the minimum comfort range, and a cash and equivalents balance of $481.25 million. The debt-to-equity ratio is 0.1, suggesting a conservative capital structure with limited leverage. However, the company has a net cash position that is negative after subtracting total debt, indicating potential liquidity constraints. ### Profitability and Returns AMETEK's profitability is reflected in an operating income of $514.94 million and a net income of $399.36 million for Q1 2026. The return on equity (ROE) is 3.66%, and the return on assets (ROA) is 2.45%, both of which are below the industry median for Electrical Components & Equipment. The company's EBITDA multiple is 106.24, and the enterprise value to revenue ratio is 28.37, suggesting that the company is valued at a premium relative to its revenue and EBITDA. ### Segments and Geographic Exposure The company operates through two primary segments: EIG and EMG. EIG focuses on advanced analytical and test and measurement instruments, while EMG provides engineered medical components and devices, automation solutions, and thermal management systems. The company's geographic exposure is not explicitly detailed in the input data, but it is implied to be global given its description as a "global provider." The acquisition of FARO Technologies in July 2025 is expected to enhance its 3D measurement and imaging solutions. ### Growth Trajectory AMETEK's growth trajectory is influenced by its recent acquisition of FARO Technologies, which is expected to expand its offerings in 3D measurement and imaging solutions. The company's capital expenditure for Q1 2026 was $25.47 million, indicating a moderate level of investment in new projects. Analysts have provided a mean price target of $254.96 and a median price target of $260.00, suggesting a positive outlook for the stock. ### Risk Factors The company faces several risk factors, including liquidity constraints due to a current ratio near the minimum comfort range and a negative net cash position after debt. The risk of dilution is medium, with source documents mentioning dilution or offering risk. Additionally, the company is in the process of finalizing the measurement of certain tangible assets and liabilities for the acquisition of FARO Technologies, which could introduce uncertainty. ### Recent Events Recent events include the FASB's issuance of ASU 2025-06, which updates guidance on accounting for internal-use software, and the OECD's proposed SbS framework to limit Pillar Two taxes for U.S.-parented groups. The company has also acquired FARO Technologies, a leading provider of 3D measurement and imaging solutions, which is expected to enhance its product offerings.

30-day price · AME+21.36 (+10.1%)
Low$207.32High$249.41Close$232.86As of14 May, 00:00 UTC
Profile
CompanyAMETEK INC/
ExchangeNYSE
TickerAME
CIK0001037868
SICIndustrial Instruments For Measurement, Display, and Control
SectorIndustrials
BusinessIndustrial Goods
Industry groupIndustrial Goods
IndustryElectrical Components & Equipment
AI analysis

Business. AMETEK, Inc. is a global provider of industrial technology solutions, operating through two segments: Electronic Instruments Group (EIG) and Electromechanical Group (EMG), which design and manufacture advanced analytical instruments, test and measurement equipment, and engineered components for industrial, aerospace, medical, and research markets.

Classification. AMETEK is classified under the Industrials sector, Industrial Goods business sector, and Electrical Components & Equipment industry, with a confidence level of 0.92 based on verified market data.

### Capital Structure and Liquidity AMETEK has a market capitalization of $54.13 billion and a price-to-earnings ratio of 135.53, indicating a high valuation relative to earnings. The company's liquidity position is characterized by a current ratio of 1.14, which is close to the minimum comfort range, and a cash and equivalents balance of $481.25 million. The debt-to-equity ratio is 0.1, suggesting a conservative capital structure with limited leverage. However, the company has a net cash position that is negative after subtracting total debt, indicating potential liquidity constraints. ### Profitability and Returns AMETEK's profitability is reflected in an operating income of $514.94 million and a net income of $399.36 million for Q1 2026. The return on equity (ROE) is 3.66%, and the return on assets (ROA) is 2.45%, both of which are below the industry median for Electrical Components & Equipment. The company's EBITDA multiple is 106.24, and the enterprise value to revenue ratio is 28.37, suggesting that the company is valued at a premium relative to its revenue and EBITDA. ### Segments and Geographic Exposure The company operates through two primary segments: EIG and EMG. EIG focuses on advanced analytical and test and measurement instruments, while EMG provides engineered medical components and devices, automation solutions, and thermal management systems. The company's geographic exposure is not explicitly detailed in the input data, but it is implied to be global given its description as a "global provider." The acquisition of FARO Technologies in July 2025 is expected to enhance its 3D measurement and imaging solutions. ### Growth Trajectory AMETEK's growth trajectory is influenced by its recent acquisition of FARO Technologies, which is expected to expand its offerings in 3D measurement and imaging solutions. The company's capital expenditure for Q1 2026 was $25.47 million, indicating a moderate level of investment in new projects. Analysts have provided a mean price target of $254.96 and a median price target of $260.00, suggesting a positive outlook for the stock. ### Risk Factors The company faces several risk factors, including liquidity constraints due to a current ratio near the minimum comfort range and a negative net cash position after debt. The risk of dilution is medium, with source documents mentioning dilution or offering risk. Additionally, the company is in the process of finalizing the measurement of certain tangible assets and liabilities for the acquisition of FARO Technologies, which could introduce uncertainty. ### Recent Events Recent events include the FASB's issuance of ASU 2025-06, which updates guidance on accounting for internal-use software, and the OECD's proposed SbS framework to limit Pillar Two taxes for U.S.-parented groups. The company has also acquired FARO Technologies, a leading provider of 3D measurement and imaging solutions, which is expected to enhance its product offerings.
Key takeaways
  • AMETEK has a high valuation with a price-to-earnings ratio of 135.53 and a market capitalization of $54.13 billion.
  • The company's liquidity position is constrained, with a current ratio of 1.14 and a negative net cash position after debt.
  • Profitability metrics such as ROE and ROA are below industry medians, indicating room for improvement.
  • The acquisition of FARO Technologies is expected to expand AMETEK's 3D measurement and imaging solutions.
  • Analysts have a positive outlook, with a mean price target of $254.96 and a median price target of $260.00.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodQ1 2026
CurrencyUSD
Revenue$1.93B
Gross profit
Operating income$514.9M
Net income$399.4M
R&D
SG&A$29.8M
D&A
SBC$9.7M
Operating cash flow$451.5M
CapEx$25.5M
Free cash flow$426.0M
Total assets$16.31B
Total liabilities$5.39B
Total equity$10.92B
Cash & equivalents$481.2M
Long-term debt$1.06B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$7.40B$1.91B$1.48B$1.67B
FY2024$6.94B$1.78B$1.38B$1.70B
FY2025$6.94B$1.78B$1.38B$1.70B
FY2024$6.60B$1.71B$1.31B$1.60B
FY2025$6.60B$1.71B$1.31B$1.60B
PeriodGross %Op %Net %FCF %
FY2025
FY2024
FY2025
FY2024
FY2025
PeriodAssetsEquityCashDebt
FY2025$16.07B$10.63B$458.0M
FY2024$14.63B$9.66B$374.0M
FY2025$14.63B$9.66B$374.0M
FY2024$15.02B$8.73B$409.8M
FY2025$15.02B$8.73B
PeriodOCFCapExFCFSBC
FY2025$1.80B$130.2M$1.67B$47.8M
FY2024$1.83B$127.1M$1.70B$47.9M
FY2025$1.83B$127.1M$1.70B$47.9M
FY2024$1.74B$136.2M$1.60B$46.2M
FY2025$1.74B$136.2M$1.60B$46.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q1 2026$1.93B$514.9M$399.4M$426.0M
Q1 2026
Q3 2025$5.40B$1.40B$1.08B$1.14B
Q2 2025$3.51B$916.5M$710.1M$724.3M
PeriodGross %Op %Net %FCF %
Q1 2026
Q1 2026
Q3 2025
Q2 2025
PeriodAssetsEquityCashDebt
Q1 2026$16.31B$10.92B$481.2M
Q1 2026$16.07B$10.63B$458.0M
Q3 2025$16.18B$10.53B$439.2M
Q2 2025$15.27B$10.39B$619.7M
PeriodOCFCapExFCFSBC
Q1 2026$451.5M$25.5M$426.0M$9.7M
Q1 2026
Q3 2025$1.22B$73.3M$1.14B$35.2M
Q2 2025$776.6M$52.3M$724.3M$22.3M
Valuation
Market price$235.50
Market cap$54.13B
Enterprise value$54.71B
P/E135.5
Reported non-GAAP P/E
EV/Revenue28.4
EV/Op income106.2
EV/OCF121.2
P/B
P/Tangible book
Tangible book-$512.1M
Net cash-$581.4M
Current ratio1.1
Debt/Equity0.1
ROA2.5%
ROE3.7%
Cash conversion1.1%
CapEx/Revenue1.3%
SBC/Revenue0.5%
Asset intensity0.1
Dilution ratio0.4%
Risk assessment
Dilution riskMedium
Liquidity riskHigh
  • Current ratio is close to the minimum comfort range.
  • Net cash is negative after subtracting total debt.
  • Source documents mention dilution or offering risk.
Industry benchmarks
Activity: Industrial Goods · cohort 13 companies
MetricAMEActivity
Op margin26.7%9.4% medp25 9.4% · p75 9.4%top quartile
Net margin20.7%5.8% medp25 5.8% · p75 5.8%top quartile
Gross margin26.9% medp25 26.9% · p75 26.9%
R&D / revenue2.0% medp25 1.6% · p75 3.0%
CapEx / revenue1.3%2.4% medp25 1.6% · p75 3.3%bottom quartile
Debt / equity10.0%106.4% medp25 106.4% · p75 106.4%bottom quartile
Observations
IR observations
Mean price target254.96 USD
Median price target260.00 USD
High price target280.00 USD
Low price target211.33 USD
Mean recommendation2.24 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count14.00
Hold count6.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate8.08 USD
Last actual EPS7.43 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0001037868 · 528 us-gaap concepts
2026-05-01 05:07 UTC#df740cba
Market quoteclose USD 235.50 · shares 0.23B diluted
no public URL
2026-05-01 05:07 UTC#7dcafcf5
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 05:08 UTCJob: dbb184fc